Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Paraffin Wax Therapy and Dry Cupping on Pain Intensity and Wrist Joint Functional Performance For Patients With Rheumatoid Arthritis

NCT07905651 is registered in ClinicalTrials.gov with University of Baghdad as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07905651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Paraffin Wax Therapy and Dry Cupping on Pain Intensity and Wrist Joint Functional Performance For Patients With Rheumatoid Arthritis
Lead sponsor
University of Baghdad
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 25, 2026
Completion date
December 26, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatic arthritis

Arms

As registered; 2 arms.

  • Paraffin wax therapy ExperimentalParaffin Wax Therapy

    Participants assigned to this group will receive paraffin wax therapy for the wrist and hand joints at a temperature of 45 ± 1°C. The treatment will involve eight successive dips, followed by wrapping the treated area for 15 minutes. The intervention will be administered twice weekly for four weeks, for a total of eight sessions.

  • Dry cupping ExperimentalDry cupping

    Participants assigned to this group will receive dry cupping therapy using suction cups applied to the designated treatment points around the wrist and hand. The procedure will be performed without skin incision or bloodletting. The treatment points, suction intensity, session duration, and frequency will follow the approved study protocol.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in Pain Intensity Measured by the Visual Analog Scale (VAS) From baseline (before the first treatment session) to completion of the 4-week intervention period (after the eighth treatment session).

    Pain intensity will be assessed using the Visual Analog Scale (VAS) before the first treatment session and after completion of the eight treatment sessions. Changes in pain intensity will be evaluated and compared between the paraffin wax therapy and dry cupping groups.

Papers

PubMed papers this trial cites; 29 papers, results papers first, then newest first.

+24 more papers

Source: PubMed, NCBI/NLM (public domain).

Lead sponsor's other trials

University of Baghdad, most recent start first.

Similar trials

Same condition (Rheumatic Fever) and phase, most recent start first.